Disease initially established as stage i (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) oncology; disease status; limited to non-small cell lung cancer; extent of
This is the 2006 version of HCPCS G9063 - please refer to the 2016 HCPCS code set for the latest version.
